• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Oyama Tetsunari  小山 徹也

ORCIDConnect your ORCID iD *help
… Alternative Names

OYAMA TETSUNARI  小山 徹也

OYAMA Tetsunari  小山 徹也

Less
Researcher Number 50233622
Other IDs
External Links
Affiliation (Current) 2025: 群馬大学, 大学院医学系研究科, 教授
Affiliation (based on the past Project Information) *help 2019 – 2021: 群馬大学, 大学院医学系研究科, 教授
2016 – 2017: 群馬大学, 大学院医学系研究科, 教授
2015: 群馬大学, 医学(系)研究科(研究院), 教授
2011 – 2013: 群馬大学, 医学(系)研究科(研究院), 教授
2002 – 2004: 群馬大学, 医学部, 助教授 … More
1999 – 2000: 群馬大学, 医学部, 助教授
1997: Gunma University School Dept of Pathology Assoiate Professor, 医学部, 助教授
1996: 群馬大学, 医学部・第二病理, 講師
1995: 群馬大学, 医学部, 講師
1994: 群馬大学, 医学部・病理学第二講座, 講師 Less
Review Section/Research Field
Principal Investigator
Human pathology / Human pathology / Basic Section 49020:Human pathology-related
Except Principal Investigator
Human pathology / Urology
Keywords
Principal Investigator
乳癌 / AIB1 / 異型嚢状小葉 / 前癌病変 / breast cancer / 次世代セークエンサー / 組織マイクロアレイ / トリプルネガティブ乳癌 / fibrillin2 / TILs … More / PDL-1 / 次世代シークエンサー / AI / デジタル画像 / 新規遺伝子 / TN乳癌 / 病理組織 / パネル診断 / 次世代PCR / トリプルネガティブ / GPR124 / IGF2BP3 / LentiPlex / CPA4 / CASP14 / breast / CPA-4 / CASP-14 / shRNA / TNBC / HORMONE RECEPTOR / ATYPICAL CYSTIC LOBULES / CARCINOGENESIS / 14-3-3 SIGUMA PROTEIN / BREAST CANCER / 異型乳管過形成 / 病理 / 非浸潤性乳管癌 / CCHA / ホルモンレセプター / 癌化 / 14-3-3σ蛋白 / osteopontin / receptor-co activator / estrogen receptor / atypical cystic lobules / precursor lesion / エストロジエンレセプター / オステオポンチン / レセプターコアクチベーター / エストロジェンレセプター / Lobular neoplasia / CyclinD1 / Precursor Lesion / Atypical cystic lobule / Breast / clonality / 乳腺 / polysomy / triple negative cancer / ALDH1 / CD44 / xCT / amplification / ductal component / EGFR / CD98 / LAT1 / triple negative / C-met / N-ras / 分化癌 / 甲状腺 / immunohistochemistry / ductal Component / Conservative therapy / Dreast Cancer … More
Except Principal Investigator
Immunohistochemistry / 免疫組織化学 / prediction / recurrence / hormone refractory / prostate / nuclear receptor / coactivator / receptor / androgen / 予測 / 再燃 / ホルモン抵抗性 / 前立腺 / 核内受容体 / 共役因子 / 受容体 / アンドロゲン / DNA methylation / Colon cancer / Breast cancer / Lung cancer / Epithelial cells / 14-3-3 sigma protein / 偏平上皮癌 / 筋上皮細胞 / 基底細胞 / 扁平上皮 / 腫瘍組織 / 正常組織 / 遺伝子メチル化 / 大腸癌 / 乳癌 / 肺癌 / 上皮細胞 / 14-3-3σ蛋白 / p53 pathway / RB pathway / Cell cycle regulator proteins / Human cancers / p53蛋白 / pRb蛋白 / CDK / p16蛋白 / 細胞回転 / Rb経路 / p53経路 / RB経路 / 細胞周期制御蛋白 / ヒト癌 Less
  • Research Projects

    (11 results)
  • Research Products

    (34 results)
  • Co-Researchers

    (18 People)
  •  TN breast cancer histological analysis using the next generation PCR to create cancer gene panel testingPrincipal Investigator

    • Principal Investigator
      OYAMA TETSUNARI
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 49020:Human pathology-related
    • Research Institution
      Gunma University
  •  New analysis of triple negative breast cancer by using LentiPlexPrincipal Investigator

    • Principal Investigator
      Oyama Tetsunari
    • Project Period (FY)
      2015 – 2017
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Human pathology
    • Research Institution
      Gunma University
  •  LAT1 expression and triple negative breast cancerPrincipal Investigator

    • Principal Investigator
      OYAMA TETSUNARI
    • Project Period (FY)
      2011 – 2013
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Human pathology
    • Research Institution
      Gunma University
  •  Study of 14-3-3 sigma protein in normal and neoplastic tissues.

    • Principal Investigator
      NAKAJIMA Takashi
    • Project Period (FY)
      2002 – 2003
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Human pathology
    • Research Institution
      Gunma University
  •  Prediction of hormone refractory recurrence of prostate cancer by androgen receptor specific coactivator p120β

    • Principal Investigator
      FUKABORI Yoshitatsu
    • Project Period (FY)
      2002 – 2004
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Urology
    • Research Institution
      Dokkyo University, School of Medicine
      Gunma University
  •  HISTOPATHOLOGICAL RESEARCH OF CARCINOGENESIS OF DUCTAL CARCINOMA IN SITUPrincipal Investigator

    • Principal Investigator
      OYAMA Tetsunari
    • Project Period (FY)
      2002 – 2003
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Human pathology
    • Research Institution
      GUNMA UNIVERSITY
  •  ヒト癌におけるP16-COK-Rb細胞回転異常に関する病理学的研究

    • Principal Investigator
      NAKAJIMA Takashi
    • Project Period (FY)
      1999 – 2000
    • Research Category
      Grant-in-Aid for Scientific Research (B).
    • Research Field
      Human pathology
    • Research Institution
      Gunma University
  •  EXPRESSION OF ESTROGEN RECEPTOR (ER) AND ER-RELATED PROTEIN IN THE PRECURSOR LESION AND ERALY LESION OF BREAST CANCERPrincipal Investigator

    • Principal Investigator
      OYAMA Tetsunari
    • Project Period (FY)
      1999 – 2000
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Human pathology
    • Research Institution
      GUNMA UNIVERSITY SCHOOL OF MEDICINE
  •  A clonality analysis of endocrine tumor and tumor-like lesionPrincipal Investigator

    • Principal Investigator
      OYAMA Tetsunari
    • Project Period (FY)
      1996 – 1997
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Human pathology
    • Research Institution
      Gunma University School of Medicine
  •  甲状腺分化癌の発生に関する分子病理学的検討-ras,trk,met oncogeneに焦点を絞ってPrincipal Investigator

    • Principal Investigator
      小山 徹也
    • Project Period (FY)
      1995
    • Research Category
      Grant-in-Aid for Encouragement of Young Scientists (A)
    • Research Field
      Human pathology
    • Research Institution
      Gunma University
  •  乳癌における乳管内成分の検討-免疫組織学的、分子病理学的解析-Principal Investigator

    • Principal Investigator
      小山 徹也
    • Project Period (FY)
      1994
    • Research Category
      Grant-in-Aid for Encouragement of Young Scientists (A)
    • Research Field
      Human pathology
    • Research Institution
      Gunma University

All 2022 2021 2020 2019 2018 2017 2016 2015 2013 2012 2011 Other

All Journal Article Presentation

  • [Journal Article] Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer.2022

    • Author(s)
      Sasagu Kurozumi, Kyoichi Kaira, Hiroshi Matsumoto, Masafumi Kurosumi, Takehiko Yokobori, Yoshikatsu Kanai, Chikako Sekine, Chikako Honda, Ayaka Katayama, Mio Furuya, Sho Shiino, Takaya Makiguchi, Nigel P Mongan, Emad A Rakha, Tetsunari Oyama, Takaaki Fujii, Ken Shirabe, Jun Horiguchi
    • Journal Title

      Scientific reports

      Volume: 12(1) Issue: 1

    • DOI

      10.1038/s41598-022-06615-8

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K07456, KAKENHI-PROJECT-19H03407
  • [Journal Article] Prognostic value of tumor-infiltrating lymphocytes in estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer.2021

    • Author(s)
      Chikako Honda, Sasagu Kurozumi, Ayaka Katayama, Bishoy Hanna-Khalil, Kei Masuda, Yuko Nakazawa, Misato Ogino, Sayaka Obayashi, Reina Yajima, Takaya Makiguchi, Tetsunari Oyama, Jun Horiguchi, Ken Shirabe, Takaaki Fujii
    • Journal Title

      Molecular and clinical oncology

      Volume: 15 252 Issue: 6 Pages: 1-6

    • DOI

      10.3892/mco.2021.2414

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K07456
  • [Journal Article] VEGF-A Is Associated With the Degree of TILs and PD-L1 Expression in Primary Breast Cancer.2020

    • Author(s)
      Fujii T, Hirakata T, Kurozumi S, Tokuda S, Nakazawa Y, Obayashi S, Yajima R, Oyama T, Shirabe K.
    • Journal Title

      In Vivo.

      Volume: 34(5) Issue: 5 Pages: 2641-2646

    • DOI

      10.21873/invivo.12082

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K07456
  • [Journal Article] FDG uptake reflects breast cancer immunological features: the PD-L1 expression and degree of TILs in primary breast cancer.2020

    • Author(s)
      Hirakata T, Fujii T, Kurozumi S, Katayama A, Honda C, Yanai K, Tokuda S, Nakazawa Y, Obayashi S, Yajima R, Kaira K, Oyama T, Shirabe K.
    • Journal Title

      Breast Cancer Res Treat

      Volume: 181 Issue: 2 Pages: 331-338

    • DOI

      10.1007/s10549-020-05619-0

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K10534, KAKENHI-PROJECT-19K07456
  • [Journal Article] Carboxypeptidase A4 accumulation is associated with an aggressive phenotype and poor prognosis in triple-negative breast cancer2019

    • Author(s)
      Handa Tadashi、Katayama Ayaka、Yokobori Takehiko、Yamane Arito、Fujii Takaaki、Obayashi Sayaka、Kurozumi Sasagu、Kawabata-Iwakawa Reika、Gombodorj Navchaa、Nishiyama Masahiko、Asao Takayuki、Shirabe Ken、Kuwano Hiroyuki、Oyama Tetsunari
    • Journal Title

      International Journal of Oncology

      Volume: Mar;54(3) Pages: 833-844

    • DOI

      10.3892/ijo.2019.4675

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07665, KAKENHI-PROJECT-17K15038, KAKENHI-PROJECT-17K19893, KAKENHI-PROJECT-19K07456
  • [Journal Article] Expression patterns of claudins in patients with triple-negative breast cancer are associated with nodal metastasis and worse outcome.2017

    • Author(s)
      Katayama A, Handa T, Komatsu K, Togo M, Horiguchi J, Nishiyama M, Oyama T.
    • Journal Title

      Pathol Int.

      Volume: 67(8) Issue: 8 Pages: 404-413

    • DOI

      10.1111/pin.12560

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-15K08339
  • [Journal Article] Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.2017

    • Author(s)
      Obayashi S, Horiguchi J, Higuchi T, Katayama A, Handa T, Altan B, Bai T, Bao P, Bao H, Yokobori T, Nishiyama M, Oyama T, Kuwano H.
    • Journal Title

      Int J Oncol.

      Volume: 51(3) Issue: 3 Pages: 781-790

    • DOI

      10.3892/ijo.2017.4085

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-15K08339
  • [Journal Article] Caspase14 expression is associated with triple negative phenotypes and cancer stem cell marker expression in breast cancer patients2017

    • Author(s)
      Tadashi Handa, Ayaka Katayama, Takehiko Yokobori, Arito Yamane, Jun Horiguchi, Takaaki Fujii, Reika Iwakawa-Kawabata, Shinji Yoshiyama, Susumu Rokudai, Pinjie Bao, Navchaa Gombodorj, Halin Bao, Bolag Altan, Kyoichi Kaira, Takayuki Asao, Hiroyuki Kuwano, Masahiko Nishiyama, and Tetsunari Oyama
    • Journal Title

      Journal of Surgical Oncology

      Volume: in press

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-15K08339
  • [Journal Article] Caspase14 expression is associated with triple negative phenotypes and cancer stem cell marker expression in breast cancer patients2017

    • Author(s)
      Handa Tadashi、Katayama Ayaka、Yokobori Takehiko、Yamane Arito、Horiguchi Jun、Kawabata-Iwakawa Reika、Rokudai Susumu、Bao Pinjie、Gombodorj Navchaa、Altan Bolag、Kaira Kyoichi、Asao Takayuki、Kuwano Hiroyuki、Nishiyama Masahiko、Oyama Tetsunari
    • Journal Title

      Journal of Surgical Oncology

      Volume: 116 Issue: 6 Pages: 706-715

    • DOI

      10.1002/jso.24705

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K15038, KAKENHI-PROJECT-15K08339
  • [Journal Article] Diagnostic usefulness of F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma.2013

    • Author(s)
      Nobusawa A, Kim M, Kaira K, Miyashita G, Negishi A, Oriuchi N, Higuchi T, Tsushima Y, Kanai Y, Yokoo S, Oyama T.
    • Journal Title

      Eur J Nucl Med Mol

      Volume: 40 Issue: 11 Pages: 1692-1700

    • DOI

      10.1007/s00259-013-2477-9

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23590388, KAKENHI-PROJECT-24390217, KAKENHI-PROJECT-24659116, KAKENHI-PROJECT-25461801
  • [Journal Article] Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer.2012

    • Author(s)
      Nakajima H, Ishikawa Y, Furuya M, Sano T, Ohno Y, Horiguchi J, Oyama T
    • Journal Title

      Breast Cancer

      Volume: Apr 6 Issue: 1 Pages: 66-74

    • DOI

      10.1007/s12282-012-0354-1

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23590388
  • [Journal Article] Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis2012

    • Author(s)
      Mio Furuya, Jun Horiguchi, Hiroki Nakajima, Yoshikatsu Kanai and Tetsunari Oyama1
    • Journal Title

      Cancer Science

      Volume: 103 Pages: 382-389

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23590388
  • [Journal Article] Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis2012

    • Author(s)
      Furuya M, Horiguchi J, Nakajima H, Kanai Y, Oyama T
    • Journal Title

      Cancer Sci

      Volume: 103 Issue: 2 Pages: 382-389

    • DOI

      10.1111/j.1349-7006.2011.02151.x

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21390264, KAKENHI-PROJECT-23590388
  • [Journal Article] Triple-negative breast cancer: Histological subtypes and immunohistochemical and clinicopathological features2011

    • Author(s)
      Yuko Ishikawa,Jun Horiguchi, Hiroyuki Toya, Hiroki Nakajima, Mitsuhiro Hayashi, Nobumi Tagaya, Takeyoshi I, Oyama T
    • Journal Title

      Cancer Science

      Volume: 102 Pages: 656-662

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23590388
  • [Journal Article] Triple-negative breast cancer: histological subtypes and immunohistochemical and clinicopathological features2011

    • Author(s)
      Ishikawa Y, Horiguchi J, Toya H, Nakajima H, Hayashi M, Tagaya N, Takeyoshi I, Oyama T
    • Journal Title

      Cancer Sci

      Volume: 102 (3) Issue: 3 Pages: 656-62

    • DOI

      10.1111/j.1349-7006.2011.01858.x

    • Data Source
      KAKENHI-PROJECT-23590388
  • [Journal Article] Tissue microarray を利用した乳癌のStem cell marker 及びアミノ酸トランスポーター発現の検討

    • Author(s)
      半田正、本田周子、矢島尚生、片山彩香、井出宗則、時庭英彰、堀口淳、金井好克、小山徹也
    • Journal Title

      乳癌基礎研

      Volume: (in press)

    • Data Source
      KAKENHI-PROJECT-23590388
  • [Presentation] 乳癌における形態学的特徴から遺伝子発現レベルを予測できる人工知能システムの開発2021

    • Author(s)
      渡辺 由佳子, 黒住 献, 横堀 武彦, 本田 周子, 増田 恵, 成澤 瑛理子, 関根 速子, 吉良 元, 小山 徹也, 藤井 孝明, 堀口 淳, 佐伯 浩司, 調 憲, 浅尾 高行
    • Organizer
      日本外科学会定期学術集会抄録集 121回
    • Data Source
      KAKENHI-PROJECT-19K07456
  • [Presentation] AI診断の新たな展望 乳がんの分子病理学的特徴の解明のためのデジタルテクノロジーを用いた新たな医学研究手法の開発2021

    • Author(s)
      黒住 献, 本田 周子, 片山 彩香, 渡辺 由佳子, 関根 速子, 川端 麗香, 横堀 武彦, Graham Ball, 藤井 孝明, 浅尾 高行, 小山 徹也, 堀口 淳
    • Organizer
      日本乳癌学会総会プログラム抄録集 29回
    • Data Source
      KAKENHI-PROJECT-19K07456
  • [Presentation] 形態病理と分子病理の新たな展望(Exploring the key molecular drivers of TILs in breast cancer using a novel machine learning platform)2021

    • Author(s)
      本田 周子, 黒住 献, 片山 彩香, 横堀 武彦, 成澤 瑛理子, 中澤 祐子, 荻野 美里, 尾林 紗弥香, 矢島 玲奈, Ball Graham, 堀口 淳, 小山 徹也, 藤井 孝明, 浅尾 高行, 調 憲
    • Organizer
      日本乳癌学会総会プログラム抄録集 29回
    • Data Source
      KAKENHI-PROJECT-19K07456
  • [Presentation] Triple negative breast cancer(TNBC)における新規治療標的候補Fibrillin 2 (FBN2)発現の臨床的意義2020

    • Author(s)
      金澤彩乃 小山徹也 他
    • Organizer
      第109回日本病理学会総会
    • Data Source
      KAKENHI-PROJECT-19K07456
  • [Presentation] Clinical significance of new treatment target candidate Carboxypeptidase A4 (CPA4) expression in the triple negative breast cancer2018

    • Author(s)
      半田正、片山彩香、横堀武彦、山根有人、川端麗香、藤井孝明、佐野孝昭、西山正彦、小山徹也
    • Organizer
      第107回日本病理学会総会(予定)
    • Data Source
      KAKENHI-PROJECT-15K08339
  • [Presentation] Caspase14 expression is associated with triple negative phenotypes and cancer stem cell marker expression in breast cancer patients.2018

    • Author(s)
      Y Ishikawa, T Handa, A Katayama, T Fujii, J Horiguchi, Y Iino, T Fujita, T Oyama
    • Organizer
      European Breast Cancer Conference 11
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K08339
  • [Presentation] Clinical significance of IGF2BP3 expression in Triple Negative Breast Cancers2017

    • Author(s)
      半田正、横堀武彦、片山彩香、山根有人、川端麗香、吉山伸司、堀口淳、佐野孝昭、西山正彦、小山徹也
    • Organizer
      第106会日本病理学会総会
    • Data Source
      KAKENHI-PROJECT-15K08339
  • [Presentation] Triple negative乳癌における新規治療標的候補CASP14発現の臨床的意義2016

    • Author(s)
      半田正、横堀武彦、川端麗香、片山彩香、小松恵、山根有人、吉山伸司、堀口淳、西山正彦、小山徹也
    • Organizer
      第25回乳癌基礎研究会
    • Place of Presentation
      奈良
    • Year and Date
      2016-07-23
    • Data Source
      KAKENHI-PROJECT-15K08339
  • [Presentation] Triple negative乳癌の標的としてshRNA screeningにより 検出されたGPR124の乳癌における発現2015

    • Author(s)
      半田正、片山彩香、山根有人、吉山伸司、堀口淳、西山正彦、 小山徹也
    • Organizer
      第24回乳癌基礎研究会
    • Place of Presentation
      スパリゾートハワイアンズ(いわき 福島)
    • Year and Date
      2015-09-05
    • Data Source
      KAKENHI-PROJECT-15K08339
  • [Presentation] Tissue microarray を利用した乳癌のStem cell marker 及びアミノ酸トランスポーター発現の検討2013

    • Author(s)
      半田正, 本田周子, 小山徹也 他
    • Organizer
      第22回乳癌基礎研究会
    • Place of Presentation
      三重
    • Year and Date
      2013-07-21
    • Data Source
      KAKENHI-PROJECT-23590388
  • [Presentation] 乳癌特にTNBC におけるAquaporin の発現2013

    • Author(s)
      半田正, 古谷未央, 小山徹也 他
    • Organizer
      第102回日本乳癌学会総会
    • Place of Presentation
      札幌
    • Year and Date
      2013-06-06
    • Data Source
      KAKENHI-PROJECT-23590388
  • [Presentation] Dual color in situ hybridization and mutational analysis of triple negative breast cancer with EGFR protein overexpression2012

    • Author(s)
      Hiroki Nakajima, Yuko Ishikawa, Yasumasa Mitani, Mio Furuya, Yoshihiro Ohno, Jun Horiguchi, Takaaki Sano, Tetsunari Oyama
    • Organizer
      第8回ヨーロッパ乳癌学会
    • Place of Presentation
      ウイーン オーストリア
    • Data Source
      KAKENHI-PROJECT-23590388
  • [Presentation] Triple-negative 乳癌におけるEGFRタンパク発現と遺伝子異常の検討2012

    • Author(s)
      片山彩香, 中島弘樹, 小山徹也他
    • Organizer
      第101回日本乳癌学会
    • Place of Presentation
      東京
    • Year and Date
      2012-04-28
    • Data Source
      KAKENHI-PROJECT-23590388
  • [Presentation] Dual color in situ hybridization and mutational analysis of triple negative breast cancer with EGFR protein overexpression2012

    • Author(s)
      Nakajima H, Ishikawa Y, Oyama T et al
    • Organizer
      EBCC8
    • Place of Presentation
      Vienna, Austria
    • Year and Date
      2012-03-22
    • Data Source
      KAKENHI-PROJECT-23590388
  • [Presentation] 乳癌におけるKi-67の検索の諸問題2011

    • Author(s)
      小山徹也, 片野未央, 堀口淳 他
    • Organizer
      第100回日本病理学会総会
    • Place of Presentation
      横浜
    • Year and Date
      2011-04-29
    • Data Source
      KAKENHI-PROJECT-23590388
  • [Presentation] 乳癌におけるKi-67の検索の諸問題(あらたなバイオマーカーLAT1発現も加えて)2011

    • Author(s)
      小山徹也、片野未央、堀口淳、黒住昌史、金井佳克
    • Organizer
      第100回日本病理学会総会
    • Place of Presentation
      神奈川 パシフィコ横浜
    • Data Source
      KAKENHI-PROJECT-23590388
  • [Presentation] 乳癌とくにTNBCにおけるAquaporinの発現

    • Author(s)
      半田正・古谷未央・井出宗則・瀬川篤記・佐野孝昭・堀口淳・福田利夫・小山徹也
    • Organizer
      第102回日本病理学会総会
    • Place of Presentation
      札幌(ロイトン札幌)
    • Data Source
      KAKENHI-PROJECT-23590388
  • [Presentation] Tissue microarrayを利用した乳癌のstem cell marker及びアミノ酸トランスポーター発現の検討

    • Author(s)
      半田正、本田周子、矢島尚生、片山彩香、井出宗則、時庭英彰、堀口淳、金井好克、小山徹也
    • Organizer
      第22回乳癌基礎研究会
    • Place of Presentation
      三重(三重大学)
    • Data Source
      KAKENHI-PROJECT-23590388
  • 1.  SANO Takaaki (90292581)
    # of Collaborated Projects: 4 results
    # of Collaborated Products: 0 results
  • 2.  KASHIWABARA Kenji (80242634)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 3.  NAKAJIMA Takashi (20124422)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 4.  FUKABORI Yoshitatsu (90199167)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 5.  MONDEN Tsuyoshi (20323363)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 6.  SHIBATA Yasuhiro (90344936)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 7.  片山 彩香 (60815695)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 4 results
  • 8.  MAEDA Masahiro
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 9.  YAMANE Arito
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 5 results
  • 10.  前田 雅昭
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 11.  FUJII Takaaki
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 12.  桑野 博行
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 13.  横堀 武彦
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 14.  黒住 献
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 15.  矢島 玲奈
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 16.  尾林 紗弥香
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 17.  川端 麗香
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 18.  金井 好克
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi